{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T14:17:21Z","timestamp":1771078641571,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics &amp; Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.ejogrb.2013.12.001","type":"journal-article","created":{"date-parts":[[2013,12,12]],"date-time":"2013-12-12T02:31:50Z","timestamp":1386815510000},"page":"86-90","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["A potential novel strategy, inhibition of vasopressin-induced VEGF secretion by relcovaptan, for decreasing the incidence of ovarian hyperstimulation syndrome in the hyperstimulated rat model"],"prefix":"10.1016","volume":"174","author":[{"given":"Cahit","family":"Cenksoy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pinar Ozcan","family":"Cenksoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ozlem","family":"Erdem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Banu","family":"Sancak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rifat","family":"Gursoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2013.12.001_bib0005","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0015-0282(16)43508-9","article-title":"Ovarian hyperstimulation syndrome: a current survey","volume":"30","author":"Schenker","year":"1978","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2013.12.001_bib0010","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1080\/14647270601111239","article-title":"Review of the evidence base of strategies to prevent ovarian hyperstimulation syndrome","volume":"10","author":"Mathur","year":"2007","journal-title":"Hum Fertil"},{"key":"10.1016\/j.ejogrb.2013.12.001_bib0015","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.bpobgyn.2012.04.004","article-title":"Prevention and management of ovarian hyperstimulation syndrome","volume":"26","author":"Chen","year":"2012","journal-title":"Best Pract Res: Clin Obstet Gynaecol"},{"key":"10.1016\/j.ejogrb.2013.12.001_bib0020","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/humrep\/13.1.30","article-title":"Serum concentration of vascular endothelial growth factor cannot predict the course of severe ovarian hyperstimulation syndrome","volume":"13","author":"Ludwig","year":"1998","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2013.12.001_bib0025","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1093\/humrep\/dei180","article-title":"Criteria of a successful coasting protocol for the prevention of severe ovarian hyperstimulation syndrome","volume":"20","author":"Mansour","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2013.12.001_bib0030","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/S1472-6483(10)60668-2","article-title":"Low-dose HCG is useful in preventing OHSS in high-risk women without adversely affecting the outcome of IVF cycles","volume":"14","author":"Nargund","year":"2007","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.ejogrb.2013.12.001_bib0035","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/humupd\/3.3.255","article-title":"The role of vascular endothelial growth factor and interleukins in the pathogenesis of severe ovarian hyperstimulation syndrome","volume":"3","author":"Rizk","year":"1997","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ejogrb.2013.12.001_bib0040","first-page":"CD008605","article-title":"Cabergoline for preventing ovarian hyperstimulation syndrome","volume":"2","author":"Tang","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ejogrb.2013.12.001_bib0045","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ejogrb.2012.08.008","article-title":"Can dopamine agonist at a low dose reduce ovarian hyperstimulation syndrome in women at risk undergoing ICSI treatment cycles? A randomized controlled study","volume":"165","author":"Shaltout","year":"2012","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"368","key":"10.1016\/j.ejogrb.2013.12.001_bib0050","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0014-2999(99)00004-7","article-title":"Vasopressin increases vascular endothelial growth factor secretion from human vascular smooth muscle cells","volume":"26","author":"Tahara","year":"1999","journal-title":"Eur J Pharmacol"},{"issue":"9","key":"10.1016\/j.ejogrb.2013.12.001_bib0055","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/356523a0","article-title":"Molecular cloning and expression of a rat V1a arginine vasopressin receptor","volume":"356","author":"Morel","year":"1992","journal-title":"Nature"},{"issue":"28","key":"10.1016\/j.ejogrb.2013.12.001_bib0060","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/357333a0","article-title":"Molecular cloning of the receptor for human antidiuretic hormone","volume":"357","author":"Birnbaumer","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.ejogrb.2013.12.001_bib0065","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/978-1-4615-4871-3_36","article-title":"Genomic and non-genomic mechanisms of oxytocin receptor regulation","volume":"449","author":"Zingg","year":"1998","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.ejogrb.2013.12.001_bib0070","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1038\/sj.bjp.0702220","article-title":"Pharmacological characterization of the human vasopressin receptor subtypes stably expressed in Chinese hamster ovary cells","volume":"125","author":"Tahara","year":"1998","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.ejogrb.2013.12.001_bib0075","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1097\/00005344-199712000-00010","article-title":"Effect of YM087, a potent nonpeptide vasopressin antagonist, on vasopressin induced hyperplasia and hypertrophy of cultured vascular smooth-muscle cells","volume":"30","author":"Tahara","year":"1997","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.ejogrb.2013.12.001_bib0080","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1093\/humrep\/12.8.1629","article-title":"Role of progesterone in capillary permeability in hyperstimulated rats","volume":"12","author":"Ujioka","year":"1997","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2013.12.001_bib0085","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1677\/joe.0.1610393","article-title":"Gonadotropin-releasing hormone agonist has the ability to induce increased matrix metalloproteinase (MMP)-2 and membrane type 1-MMP expression in corpora lutea, and structural luteolysis in rats","volume":"161","author":"Goto","year":"1999","journal-title":"J Endocrinol"},{"key":"10.1016\/j.ejogrb.2013.12.001_bib0090","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/(SICI)1098-2795(199811)51:3<287::AID-MRD8>3.0.CO;2-L","article-title":"Regulation of follicular luteinization by a gonadotropin-releasing hormone agonist: relationship between steroidogenesis and apoptosis","volume":"51","author":"Andreu","year":"1998","journal-title":"Mol Reprod Dev"},{"key":"10.1016\/j.ejogrb.2013.12.001_bib0095","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1210\/endo-120-1-146","article-title":"Evidence for widespread atresia in the hypophysectomized estrogen-treated rat","volume":"120","author":"Sadrkhanloo","year":"1987","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejogrb.2013.12.001_bib0100","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.rbmo.2012.05.004","article-title":"GnRH antagonist rescue in high responders at risk for OHSS results in excellent assisted reproduction outcomes","volume":"25","author":"Hill","year":"2012","journal-title":"Reprod BioMed Online"},{"key":"10.1016\/j.ejogrb.2013.12.001_bib0105","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1097\/00029330-200812010-00014","article-title":"Effects of gonadotropin-releasing hormone antagonists on the expression of vascular endothelial growth factor and its receptors in a rat model of ovarian hyperstimulation syndrome","volume":"121","author":"Tong","year":"2008","journal-title":"Chin Med J"},{"key":"10.1016\/j.ejogrb.2013.12.001_bib0110","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S1472-6483(10)60046-6","article-title":"Prevention of OHSS: GnRH agonist versus HCG to trigger ovulation","volume":"19","author":"Kol","year":"2009","journal-title":"Reprod BioMed Online"},{"key":"10.1016\/j.ejogrb.2013.12.001_bib0115","first-page":"CD001750","article-title":"Gonadotrophin-releasing hormone antagonists for assisted reproductive technology","volume":"5","author":"Al-Inany","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ejogrb.2013.12.001_bib0120","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.fertnstert.2003.11.012","article-title":"Gonadotropin-releasing hormone agonist administration reduced vascular endothelial growth factor (VEGF), VEGF receptors, and vascular permeability of the ovaries of hyperstimulated rats","volume":"81","author":"Kitajima","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2013.12.001_bib0125","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0140-6736(94)93001-5","article-title":"Vascular endothelial growth factor as capillary permeability agent in ovarian hyperstimulation syndrome","volume":"344","author":"McClure","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.ejogrb.2013.12.001_bib0130","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1677\/jme.0.0200363","article-title":"The kallikrein-kinin system, but not vascular endothelial growth factor, plays a role in the increased vascular permeability associated with ovarian hyperstimulation syndrome","volume":"20","author":"Kobayashi","year":"1998","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.ejogrb.2013.12.001_bib0135","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1093\/humrep\/12.2.236","article-title":"Prorenin and active renin concentrations in plasma and ascites during severe ovarian hyperstimulation syndrome","volume":"12","author":"Delbaere","year":"1997","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2013.12.001_bib0140","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1093\/oxfordjournals.humrep.a019404","article-title":"Plasma inflammatory cytokines correlate to the ovarian hyperstimulation syndrome","volume":"11","author":"Abramov","year":"1996","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2013.12.001_bib0145","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0015-0282(98)00484-1","article-title":"The pathogenesis of ovarian hyperstimulation syndrome: in vivo studies investigating the role of interleukin-1, interleukin-6, and vascular endothelial growth factor","volume":"71","author":"Pellicer","year":"1999","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2013.12.001_bib0150","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1095\/biolreprod.102.010801","article-title":"Administration of moderate and high doses of gonadotropins to female rats increases ovarian vascular endothelial growth factor (VEGF) and VEGF receptor-2 expression that is associated to vascular hyperpermeability","volume":"68","author":"G\u00f3mez","year":"2003","journal-title":"Biol Reprod"},{"key":"10.1016\/j.ejogrb.2013.12.001_bib0155","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.fertnstert.2004.03.053","article-title":"Effect of angiotensin-converting enzyme-inhibiting therapy on the expression of vascular endothelial growth factor in hyperstimulated rat ovary","volume":"82","author":"Ozcakir","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2013.12.001_bib0160","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1530\/rep.0.1230379","article-title":"Expression of vascular endothelial growth factor (VEGF) and its receptors in human endometrium throughout the menstrual cycle and in early pregnancy","volume":"123","author":"Sugino","year":"2002","journal-title":"Reproduction"},{"key":"10.1016\/j.ejogrb.2013.12.001_bib0165","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.fertnstert.2008.01.029","article-title":"Pathophysiologic features of \u201cthin\u201d endometrium","volume":"91","author":"Miwa","year":"2009","journal-title":"Fertil Steril"}],"container-title":["European Journal of Obstetrics &amp; Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211513006040?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211513006040?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:30:45Z","timestamp":1759555845000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211513006040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":33,"alternative-id":["S0301211513006040"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2013.12.001","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A potential novel strategy, inhibition of vasopressin-induced VEGF secretion by relcovaptan, for decreasing the incidence of ovarian hyperstimulation syndrome in the hyperstimulated rat model","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2013.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}